UnitedHealth Group Incorporated’s Price-to-Earnings Ratio at a glance
UnitedHealth Group Incorporated reports price-to-earnings ratio of 32.6x for Dec 2024. The prior period recorded 21.8x (Dec 2023). Year over year the metric moved +10.79 (+49.4%). The rolling three-period average stands at 26.4x. Data last refreshed Nov 20, 2025, 11:36 PM.
Latest reading
32.6x · Dec 2024
YoY movement
+10.79 (+49.4%)
Rolling average
26.4x
Current Price-to-Earnings Ratio
32.6x
+10.79
+49.4%
Rolling average
26.4x
Latest Value
32.6x
Dec 2024
YoY Change
+10.79
Absolute
YoY Change %
+49.4%
Rate of change
3-Period Avg
26.4x
Smoothed
Narrative signal
UnitedHealth Group Incorporated’s price-to-earnings ratio stands at 32.6x for Dec 2024. Year-over-year, the metric shifted by +10.79, translating into a +49.4% rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
How price-to-earnings ratio shapes UnitedHealth Group Incorporated's story
As of Dec 2024, UnitedHealth Group Incorporated reports price-to-earnings ratio of 32.6x. Analyze price-to-earnings history, valuation swings, and relative multiples to benchmark market expectations.
Why the P/E ratio matters
The price-to-earnings multiple reveals how much investors are willing to pay for each dollar of net income. Elevated P/E levels suggest strong growth expectations or limited earnings.
Tracking valuation cycles
Monitoring multi-year P/E trends highlights how macro cycles, product launches, or profitability changes impact valuation over time.
Valuation Multiples
Compare how the market prices revenue, equity, and operating cash flow versus peers and history.
Profitability & Margins
Understand cost structure and capital efficiency trends across gross, operating, and net results.
Gross Margin
22.3%
Operating Margin
8.1%
Net Profit Margin
3.6%
Return on Equity
15.5%
Return on Assets
4.8%
Growth Momentum
Track whether top-line, earnings, and free cash flow growth are accelerating or cooling.
Balance Sheet Strength
Evaluate leverage, liquidity, and cash generation capacity that underpin resilience.
Shareholder Returns
Follow dividend sustainability and cash generation relative to market value.
UnitedHealth Group Incorporated (UNH) FAQs
Answers tailored to UnitedHealth Group Incorporated’s price-to-earnings ratio profile using the latest Financial Modeling Prep data.
What is UnitedHealth Group Incorporated's current price-to-earnings ratio?
As of Dec 2024, UnitedHealth Group Incorporated reports price-to-earnings ratio of 32.6x. This reading reflects the latest filings and price data for UNH.
How is UnitedHealth Group Incorporated's price-to-earnings ratio trending year over year?
Year-over-year, the figure shifts by +10.79 (+49.4%). Pair this context with revenue growth and free cash flow signals to gauge momentum for UNH.
Why does price-to-earnings ratio matter for UnitedHealth Group Incorporated?
The P/E ratio compares a company’s share price with its per-share earnings to gauge valuation. For UnitedHealth Group Incorporated, operating within Healthcare — Medical - Healthcare Plans, tracking this metric helps benchmark management's execution against close competitors.
Is UnitedHealth Group Incorporated's price-to-earnings ratio above its recent average?
UnitedHealth Group Incorporated's rolling three-period average sits at 26.4x. Comparing the latest reading of 32.6x to that baseline highlights whether momentum is building or fading for UNH.
How frequently is UnitedHealth Group Incorporated's price-to-earnings ratio refreshed?
Data for UNH was last refreshed on Nov 20, 2025, 11:36 PM and updates automatically every 24 hours, keeping your valuation inputs current.